Dr. Kory's Medical Lecture in Malaysia on World Ivermectin Day; receiving the Special Benevolence Award from Tan Sri Lee Kim Yew. .

Auhtors: Khandelwal A, Singh GP, Jamil S PMID: 34334890 PMCID: PMC8313054 DOI: 10.1016/j.mjafi.2021.06.002 No abstract available Keywords: Anti-viral; COVID-19; Ivermectin; SARS-CoV-2 Source: https://pubmed.ncbi.nlm.nih.gov/34334890/ Archive: https://archive.is/uArVB

A reexamination of the data without the earlier research continues to prove that ivermectin is effective in preventing and treating COVID-19

Dr. Kory on How Ivermectin Defeats the Variants + The Positive Data in Andrew Hill’s Meta-Analysis of RCTs on Ivermectin in Treating Covid-19.

Authors: Cadegiani FA, Goren A, Wambier CG, McCoy J PMID: 34249367 PMCID: PMC8262389 DOI: 10.1016/j.nmni.2021.100915 Abstract In a prospective observational study (pre-AndroCoV Trial), the use of nitazoxanide, ivermectin and hydroxychloroquine demonstrated unexpected improvements in COVID-19 outcomes when compared to untreated patients. The apparent yet likely positive results raised ethical concerns on the employment of further [...]

Authors: Hill A, Garratt A, Levi J, Falconer J, Ellis L, McCann K et al. PMID: 34796244 PMCID: PMC8420640 DOI: 10.1093/ofid/ofab358 Abstract Ivermectin is an antiparasitic drug being investigated for repurposing against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Ivermectin showed in vitro activity against SARS-COV-2, but only at high concentrations. This meta-analysis investigated ivermectin [...]

Matt Taibbi's substack examines the war on repurposed drugs and asks why has Ivermectin become a dirty word?

Sowetan Live reports that Zimbabwe approved ivermectin to treat COVID-19.

Transcript of Dr. Kory's video message on the U.S. Deal to Give $1.2 Billion Taxpayer Dollars to Merck Instead of distributing safe, effective, inexpensive ivermectin

After COVID-19 emerged on U.S shores, providers began reviewing the emerging basic science, translational, and clinical data to identify potentially effective treatment options. In addition, a multitude of both novel and repurposed therapeutic agents were used empirically and studied within clinical trials.